Key Financial Data Of Reporting Company

Oncolys BioPharma Inc. - Filing #7712866

Concept 2017-04-01 to
2017-06-30
As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
2016-01-01 to
2016-12-31
2016-04-01 to
2016-06-30
As at
2016-06-30
2016-01-01 to
2016-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
19,904,000 JPY
178,313,000 JPY
44,680,000 JPY
Ordinary profit (loss)
-517,038,000 JPY
-864,241,000 JPY
-416,970,000 JPY
Profit (loss)
-518,662,000 JPY
-931,397,000 JPY
-417,969,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
5,573,269,000 JPY
5,090,981,000 JPY
5,087,919,000 JPY
Total number of issued shares
10,455,300 xbrli:shares
9,234,600 xbrli:shares
9,225,300 xbrli:shares
Net assets
3,044,840,000 JPY
2,617,383,000 JPY
3,064,561,000 JPY
Total assets
3,602,743,000 JPY
3,140,313,000 JPY
3,581,867,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-27.94
-53.89
-101.18
-25.23
-45.51
Diluted earnings per share
Equity-to-asset ratio
0.841 xbrli:pure
0.827 xbrli:pure
0.854 xbrli:pure
Net cash provided by (used in) operating activities
-519,460,000 JPY
-903,424,000 JPY
-385,732,000 JPY
Net cash provided by (used in) investing activities
343,218,000 JPY
256,627,000 JPY
-121,120,000 JPY
Net cash provided by (used in) financing activities
1,042,018,000 JPY
6,423,000 JPY
6,200,000 JPY
Cash and cash equivalents
2,277,291,000 JPY
1,418,993,000 JPY
1,547,225,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.